Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 51 to 100 of 8289 in total
Value Type: Ranked
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
26\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome p450 27, mitochondrial precursor (ec 1.14.-.-) (cytochrome p-450c27/25) (sterol 26-hydroxylase) (sterol 27-hydroxylase) (vitamin d(3) 25-hydroxylase) (5-beta-cholestane-3-alpha,7-alpha,12-alpha-triol 27-hydroxylase). [source:swissprot;acc:q02318]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
286.347\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
238.454\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20085\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pantothenate kinase 3 (ec 2.7.1.33) (pantothenic acid kinase 3) (hpank3). [source:swissprot;acc:q9h999]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
44\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.31818\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
27\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome p450 24a1, mitochondrial precursor (ec 1.14.-.-) (p450- cc24) (vitamin d(3) 24-hydroxylase) (1,25-dihydroxyvitamin d(3) 24- hydroxylase) (24-ohase). [source:swissprot;acc:q07973]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
284.798\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
237.743\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.19792\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial solute carrier protein. [source:refseq;acc:nm\_145305]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
44\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.31818\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
28\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
atlastin; guanylate-binding protein 3. [source:refseq;acc:nm\_015915]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
142\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
170\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.19718\vspace{3pt}}\\\cline{2-6}
&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
cyclic-amp-dependent transcription factor atf-3 (activating transcription factor 3). [source:swissprot;acc:p18847]\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
201.949\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
153.671\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.31416\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
29\vspace{3pt}}}&&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
203.115\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
170.557\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.19089\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
uncharacterized hematopoietic stem/progenitor cells protein mds026. [source:sptrembl;acc:q9nz48]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
187.458\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
243.678\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.29991\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
30\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
bcl2-related ovarian killer. [source:refseq;acc:nm\_032515]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
265.638\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
223.235\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.18995\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 55 kda regulatory subunit b, alpha isoform (pp2a, subunit b, b-alpha isoform) (pp2a, subunit b, b55-alpha isoform) (pp2a, subunit b, pr55-alpha isoform) (pp2a, subunit b, r2-alpha isoform). [source:swissprot;acc:q00007]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
187.457\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
243.678\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.29991\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
31\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
deoxyribonuclease ii beta isoform 1 precursor; deoxyribonuclease ii beta; endonuclease dlad. [source:refseq;acc:nm\_021233]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
57.395\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
48.8186\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.17568\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 55 kda regulatory subunit b, beta isoform (pp2a, subunit b, b-beta isoform) (pp2a, subunit b, b55- beta isoform) (pp2a, subunit b, pr55-beta isoform) (pp2a, subunit b, r2-beta isoform). [source:swissprot;acc:q00005]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
187.458\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
243.677\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.2999\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
32\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase, interferon-inducible double stranded rna dependent activator; protein activator of the interferon-induced protein kinase. [source:refseq;acc:nm\_003690]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
273.188\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
232.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.17505\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 55 kda regulatory subunit b, gamma isoform (pp2a, subunit b, b-gamma isoform) (pp2a, subunit b, b55-gamma isoform) (pp2a, subunit b, pr55-gamma isoform) (pp2a, subunit b, r2-gamma isoform) (imypno1). [source:swissprot;acc:q9y2t4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
187.462\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
243.673\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.29985\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
33\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dual specificity mitogen-activated protein kinase kinase 4 (ec 2.7.1.-) (map kinase kinase 4) (jnk activating kinase 1) (c-jun n- terminal kinase kinase 1) (jnkk) (sapk/erk kinase 1) (sek1). [source:swissprot;acc:p45985]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.241\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
246.125\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.17068\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 65 kda regulatory subunit a, beta isoform (pp2a, subunit a, pr65-beta isoform) (pp2a, subunit a, r1-beta isoform). [source:swissprot;acc:p30154]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
188.688\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
242.742\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.28647\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
34\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative glialblastoma cell differentiation-related; putative glialblastoma cell differentiation-related protein. [source:refseq;acc:nm\_016172]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
155.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
133.876\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16197\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 65 kda regulatory subunit a, alpha isoform (pp2a, subunit a, pr65-alpha isoform) (pp2a, subunit a, r1-alpha isoform) (medium tumor antigen-associated 61 kda protein). [source:swissprot;acc:p30153]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
189.07\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
242.453\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.28235\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
35\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear transcription factor y subunit gamma (nf-y protein chain c) (nuclear factor yc) (nf-yc) (ccaat-binding transcription factor subunit c) (cbf-c) (transactivator hsm-1/2). [source:swissprot;acc:q13952]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
260.532\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.309\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.27519\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tob2 protein (transducer of erbb-2 2). [source:swissprot;acc:q14106]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
297.273\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
258.59\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14959\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
36\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ccaat-binding transcription factor subunit b (cbf-b) (nf-y protein chain a) (nf-ya) (caat-box dna binding protein subunit a). [source:swissprot;acc:p23511]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
260.532\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.309\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.27519\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tob1 protein (transducer of erbb-2 1). [source:swissprot;acc:p50616]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
296.837\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
258.33\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14906\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
37\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromatin accessibility complex protein 1 (chrac-1) (chrac-15) (huchrac15) (dna polymerase epsilon subunit p15). [source:swissprot;acc:q9nrg0]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
250.244\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.843\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14874\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14a; 17-kda pkc-potentiated inhibitory protein of pp1. [source:refseq;acc:nm\_033256]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
322\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
253\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.27273\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
38\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glucosamine-6-phosphate isomerase. [source:refseq;acc:nm\_138335]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
247.202\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
282.937\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14456\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
microfibril-associated glycoprotein 4 precursor. [source:swissprot;acc:p55083]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
322\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
253\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.27273\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
39\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glucosamine-6-phosphate isomerase (ec 3.5.99.6) (glucosamine-6- phosphate deaminase) (gnpda) (glcn6p deaminase) (oscillin). [source:swissprot;acc:p46926]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
247.202\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
282.937\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14456\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory subunit 14d; pkc-dependent pp1 inhibitory protein. [source:refseq;acc:nm\_017726]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
322\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
253\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.27273\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
40\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ficolin 2 precursor (collagen/fibrinogen domain-containing protein 2) (ficolin-b) (ficolin b) (serum lectin p35) (ebp-37) (hucolin) (l- ficolin). [source:swissprot;acc:q15485]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
son protein (son3) (negative regulatory element-binding protein) (nre- binding protein) (dbp-5) (bax antagonist selected in saccharomyces 1) (bass1) (protein c21orf50). [source:swissprot;acc:p18583]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
255.382\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
223.538\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14245\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
41\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ba127l20.1 (novel glutathione-s-transferase). [source:sptrembl;acc:q9h4y5]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
228.147\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
200.55\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13761\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14c; serologically defined breast cancer antigen ny-br-81; pkc-potentiated pp1 inhibitory protein. [source:refseq;acc:nm\_030949]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
322\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
253\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.27273\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
42\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutathione transferase omega 1 (ec 2.5.1.18) (gsto 1-1). [source:swissprot;acc:p78417]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
227.371\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
200.532\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13384\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene protein c-fos (cellular oncogene fos) (g0/g1 switch regulatory protein 7). [source:swissprot;acc:p01100]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
204.641\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
160.957\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.2714\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
43\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
jun dimerization protein. [source:refseq;acc:nm\_130469]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
regulator of g-protein signaling 12 (rgs12). [source:swissprot;acc:o14924]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
247.768\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219.841\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12703\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
44\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
fos-related antigen 2. [source:swissprot;acc:p15408]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.641\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
161.046\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.2707\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14a; 17-kda pkc-potentiated inhibitory protein of pp1. [source:refseq;acc:nm\_033256]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
242.742\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
217.217\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.11751\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
45\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
microfibril-associated glycoprotein 4 precursor. [source:swissprot;acc:p55083]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein fosb (g0/g1 switch regulatory protein 3). [source:swissprot;acc:p53539]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.641\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
161.051\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.27066\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
46\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
fos-related antigen 1 (fra-1). [source:swissprot;acc:p15407]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
204.642\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
161.068\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.27053\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory subunit 14d; pkc-dependent pp1 inhibitory protein. [source:refseq;acc:nm\_017726]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
242.742\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
217.217\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.11751\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
47\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ficolin 2 precursor (collagen/fibrinogen domain-containing protein 2) (ficolin-b) (ficolin b) (serum lectin p35) (ebp-37) (hucolin) (l- ficolin). [source:swissprot;acc:q15485]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
gbp protein isoform a. [source:refseq;acc:nm\_017870]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
325.586\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
256.492\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.26938\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
48\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
gaba(a) receptor-associated protein; gaba(a)-receptor-associated protein. [source:refseq;acc:nm\_007278]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
65.4586\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
83.0461\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.26868\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14c; serologically defined breast cancer antigen ny-br-81; pkc-potentiated pp1 inhibitory protein. [source:refseq;acc:nm\_030949]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
242.742\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.217\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11751\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
49\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-arrestin 2 (arrestin, beta 2). [source:swissprot;acc:p32121]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
133\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
105\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.26667\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
t-box transcription factor tbx19 (t-box protein 19). [source:swissprot;acc:o60806]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.438\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.569\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11289\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
50\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-arrestin 1 (arrestin, beta 1). [source:swissprot;acc:p49407]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
133\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
105\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.26667\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
junctophilin 3 (junctophilin type 3) (jp-3). [source:swissprot;acc:q8wxh2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
234.802\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
260.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11149\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/